ERVW-1 and myeloid sarcoma: Nevertheless, the 6A2B2 antibody may cross react with Syncytin-1 [16,43] and all previous neuropathological studies that reported a dysregulated expression of Syncytin-1 in MS lesions relied on the 6A2B2 antibody [18,21,22].